Macrolides: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Source==" to "==References== <references/>") |
ClaireLewis (talk | contribs) No edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
* Erythromycin, Clarithromycin, Azithromycin | *[[Erythromycin]], [[Clarithromycin]], [[Azithromycin]] | ||
** Community-acquired | **Community-acquired [[pneumonia]] | ||
** Mycoplasma | **[[Mycoplasma]] | ||
** Legionnaires' Disease | **[[Legionella|Legionnaires' Disease]] | ||
** Chlamydia (single dose) | **[[Chlamydia]] (single dose) | ||
** H. | **[[H. pylori]] | ||
** Traveler's diarrhea (children and pregnant women) | **[[Traveler's diarrhea]] (children and pregnant women) | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} | ||
Latest revision as of 23:04, 22 September 2019
- Erythromycin, Clarithromycin, Azithromycin
- Community-acquired pneumonia
- Mycoplasma
- Legionnaires' Disease
- Chlamydia (single dose)
- H. pylori
- Traveler's diarrhea (children and pregnant women)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
See Also
References
Goodman & Gilman's Pharmacology